Sep 14, 2021 / 01:30PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Great. Good morning, everybody. Thanks for joining us here. I'm Matthew Harrison, one of the biotech analysts at Morgan Stanley. Very pleased to have Editas with us for the next session. Before we get started, I just need to read a disclosure statement. Please note that all-important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures. We've got the full crew with us. So we have Jim Mullen, CEO; Mark Shearman, CSO; and Lisa Michaels, CMO. So very pleased to have you all here, and thanks for joining us.
Questions and Answers:
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive DirectorI thought maybe a good place to start as you -- you recently spent some time at Cold Spring talking about some of the newer technologies that you're working on. So maybe just talk a little bit about SLEEK and why you've made some investments there and how you
Trustpilot
